Gordon Kuntz

Review

NGS Testing in Non–Small Cell Lung Cancer

09/19/2023

Winston Wong, PharmD, and Gordon Kuntz provide an update on the current status of the research and barriers for using next-generation sequencing in NSCLC and summarize the discussion and next steps that the NGS Institute’s NSCLC Subcommittee...

Winston Wong, PharmD, and Gordon...

09/19/2023

Journal of Clinical Pathways

NGS Institute

The NGS Institute: Advancing the Appropriate Use of Biomarker Testing

02/06/2023

Gordon Kuntz ;

The NGS Institute is a trusted resource for curated, practical information on biomarker and next-generation sequencing testing. This article outlines the aim the Institute has to play a role in facilitating the integration of genomic-level...

The NGS Institute is a trusted...

02/06/2023

Journal of Clinical Pathways

JCP Special Report

Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group

05/20/2022

Robin T. Zon , MD, FACP, FASCO;

Gordon Kuntz ;

Winston Wong , PharmD;

The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...

The Journal of Clinical Pathways...

05/20/2022

Journal of Clinical Pathways

Special Article

Recommendations for Enhancing the Value of Clinical Pathways: Findings From the 2020 Care Pathways Working Group

11/16/2021

Winston Wong , PharmD;

Vasily Belozeroff , PhD;

Robin T. Zon , MD, FACP, FASCO;

Gordon Kuntz ;

Experts identified concerns related to care pathways and their implementation that need to be addressed in order to promote high-quality pathways that offer utility in payer negotiation, reduce costs, and reduce unnecessary variation in care...

Experts identified concerns...

11/16/2021

Journal of Clinical Pathways